F-group (family)
2498.1.1.1 Peptidase_M10
Ligands and drugs
754
Member domains
522
with ligand contacts (≤ 4 Å)
69.2% of members
534
with DrugDomain annotations
70.8% of members
301
with a DrugBank compound
39.9% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 2498.1.1.1 belongs to X-group 2498 Zincin-like, which binds 9.5 ligand superclasses per 20 proteins, broader than 89% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB04349 | PGO | (S)-propane-1,2-diol | 29 |
| DB00551 | HAE | Acetohydroxamic acid | 27 |
| DB00786 | — | Marimastat | 23 |
| DB08271 | NGH | N-ISOBUTYL-N-[4-METHOXYPHENYLSULFONYL]GLYCYL HYDROXAMIC ACID | 12 |
| DB07556 | CGS | CGS-27023 | 8 |
| DB07827 | GG1 | 4-{[1-METHYL-2,4-DIOXO-6-(3-PHENYLPROP-1-YN-1-YL)-1,4-DIHYDROQUINAZOLIN-3(2H)-YL]METHYL}BENZOIC ACID | 8 |
| DB04318 | RXP | Nα-[(2S)-2-{[(S)-[(1S)-1-{[(Benzyloxy)carbonyl]amino}-2-phenylethyl](hydroxy)phosphoryl]methyl}-5-phenylpentanoyl]-L-tryptophanamide | 7 |
| DB02049 | CBP | 2-{4-[4-(4-Chloro-Phenoxy)-Benzenesulfonyl]-Tetrahydro-Pyran-4-Yl}-N-Hydroxy-Acetamide | 4 |
| DB07013 | 347 | TERT-BUTYL 4-({[4-(BUT-2-YN-1-YLAMINO)PHENYL]SULFONYL}METHYL)-4-[(HYDROXYAMINO)CARBONYL]PIPERIDINE-1-CARBOXYLATE | 4 |
| DB02159 | PGR | (R)-Propylene glycol | 3 |
| DB03350 | NCO | Cobalt hexammine ion | 3 |
| DB03368 | HQQ | 5-Methyl-5-(4-Phenoxy-Phenyl)-Pyrimidine-2,4,6-Trione | 3 |
| DB03880 | BAT | Batimastat | 3 |
| DB08643 | TR1 | 2-(2-{2-[(BIPHENYL-4-YLMETHYL)-AMINO]-3-MERCAPTO-PENTANOYLAMINO}-ACETYLAMINO)-3-METHYL-BUTYRIC ACID METHYL ESTER | 3 |
| DB01197 | — | Captopril | 2 |
| DB01877 | SPC | N-Hydroxy 1n(4-Methoxyphenyl)Sulfonyl-4-(Z,E-N-Methoxyimino)Pyrrolidine-2r-Carboxamide | 2 |
| DB01949 | BUM | 2-Amino-N,3,3-Trimethylbutanamide | 2 |
| DB01996 | 3MP | 3-Methylpyridine | 2 |
| DB02071 | WAY | WAY-151693 | 2 |
| DB02350 | MM3 | N-Hydroxy-4-[(4-Methoxylphenyl)Sulfonyl]-2,2-Dimethyl-Hexahydro-1,4-Thiazepine-3(S)-Carboxamide | 2 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| ZNmetal | ZINC ION | 514 |
| CAmetal | CALCIUM ION | 488 |
| PGO | S-1,2-PROPANEDIOL | 34 |
| CL | CHLORIDE ION | 31 |
| HAE | ACETOHYDROXAMIC ACID | 27 |
| NAmetal | SODIUM ION | 21 |
| NGH | N-ISOBUTYL-N-[4-METHOXYPHENYLSULFONYL]GLYCYL HYDROXAMIC ACID | 12 |
| CGS | N-HYDROXY-2(R)-[[(4-METHOXYPHENYL)SULFONYL](3-PICOLYL)AMINO]-3-METHYLBUTANAMIDE HYDROCHLORIDE | 8 |
| GG1 | 4-{[1-METHYL-2,4-DIOXO-6-(3-PHENYLPROP-1-YN-1-YL)-1,4-DIHYDROQUINAZOLIN-3(2H)-YL]METHYL}BENZOIC ACID | 8 |
| L29 | N,N'-bis(2-{(biphenyl-4-ylsulfonyl)[(2R)-1-(hydroxyamino)-3-methyl-1-oxobutan-2-yl]amino}ethyl)benzene-1,3-dicarboxamide (non-preferred name) | 8 |
| 023 | N^2^-[(2R)-2-{(1S)-1-[FORMYL(HYDROXY)AMINO]ETHYL}-5-PHENYLPENTANOYL]-N,3-DIMETHYL-L-VALINAMIDE | 6 |
| AZI | AZIDE ION | 6 |
| CPS | 3-[(3-CHOLAMIDOPROPYL)DIMETHYLAMMONIO]-1-PROPANESULFONATE | 6 |
| RXP | 1-BENZYLOXYCARBONYLAMINO-2-PHENYL-ETHYL)-{2-[1-CARBAMOYL-2-(1H-INDOL-3-YL)-ETHYLCARBAMOYL]-5-PHENYL-PENTYL}-PHOSPHINIC ACID | 6 |
| 8O7 | N-(2-aminoethyl)-4'-(((4-oxo-4,5,6,7-tetrahydro-3H-cyclopenta[d]pyrimidin-2-yl)thio)methyl)-[1,1'-biphenyl]-4-sulfonamide | 5 |
| B9Z | (2~{S})-2-[2-[4-(4-methoxyphenyl)phenyl]sulfanylphenyl]pentanedioic acid | 5 |
| R47 | N-[(2S)-3-[(S)-(4-bromophenyl)(hydroxy)phosphoryl]-2-{[3-(3'-chlorobiphenyl-4-yl)-1,2-oxazol-5-yl]methyl}propanoyl]-L-alpha-glutamyl-L-alpha-glutamine | 5 |
| 033 | N-({4'-[(1-BENZOFURAN-2-YLCARBONYL)AMINO]-1,1'-BIPHENYL-4-YL}SULFONYL)-L-VALINE | 4 |
| 0ZD | N,N'-bis(2-[(biphenyl-4ylsulfonyl)[(2R)-1-hydroxy-3-methyl-1-oxobutan-2-yl]-amino]ethyl)benzene-1,3-dicarboxamide | 4 |
| 2HP | DIHYDROGENPHOSPHATE ION | 4 |